MX2012014971A - Fixed doses of a combination of sildenafil and dapoxetine. - Google Patents

Fixed doses of a combination of sildenafil and dapoxetine.

Info

Publication number
MX2012014971A
MX2012014971A MX2012014971A MX2012014971A MX2012014971A MX 2012014971 A MX2012014971 A MX 2012014971A MX 2012014971 A MX2012014971 A MX 2012014971A MX 2012014971 A MX2012014971 A MX 2012014971A MX 2012014971 A MX2012014971 A MX 2012014971A
Authority
MX
Mexico
Prior art keywords
dapoxetine
sildenafil
combination
fixed doses
doses
Prior art date
Application number
MX2012014971A
Other languages
Spanish (es)
Inventor
Reddy Bandi Parthasaradhi
Podili Khadgapathi
Reddy Pothireddy Venkateswar
Original Assignee
Hetlabs Mexico S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetlabs Mexico S A De C V filed Critical Hetlabs Mexico S A De C V
Priority to MX2012014971A priority Critical patent/MX2012014971A/en
Publication of MX2012014971A publication Critical patent/MX2012014971A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention refers to immediate release fixed doses of a combination of sildenafil and dapoxetine and a process for preparing the same, as well as methods for using such compositions for treating people suffering from sexual dysfunction.
MX2012014971A 2012-12-18 2012-12-18 Fixed doses of a combination of sildenafil and dapoxetine. MX2012014971A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012014971A MX2012014971A (en) 2012-12-18 2012-12-18 Fixed doses of a combination of sildenafil and dapoxetine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012014971A MX2012014971A (en) 2012-12-18 2012-12-18 Fixed doses of a combination of sildenafil and dapoxetine.

Publications (1)

Publication Number Publication Date
MX2012014971A true MX2012014971A (en) 2013-08-28

Family

ID=49552932

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014971A MX2012014971A (en) 2012-12-18 2012-12-18 Fixed doses of a combination of sildenafil and dapoxetine.

Country Status (1)

Country Link
MX (1) MX2012014971A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106511312A (en) * 2015-09-11 2017-03-22 扬子江药业集团江苏紫龙药业有限公司 Compound sildennafil dapoxetine slow-release capsule and preparation method thereof
WO2018070971A1 (en) * 2016-10-10 2018-04-19 Товарыство З Обмэжэною Видповидальнистю Науково-Выробныча Фирма "Микрохим" Pharmaceutical composition in the form of an oromucosal spray for treating erectile dysfunction and pulmonary arterial hypertension

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106511312A (en) * 2015-09-11 2017-03-22 扬子江药业集团江苏紫龙药业有限公司 Compound sildennafil dapoxetine slow-release capsule and preparation method thereof
WO2018070971A1 (en) * 2016-10-10 2018-04-19 Товарыство З Обмэжэною Видповидальнистю Науково-Выробныча Фирма "Микрохим" Pharmaceutical composition in the form of an oromucosal spray for treating erectile dysfunction and pulmonary arterial hypertension

Similar Documents

Publication Publication Date Title
MD20150091A2 (en) Anti-viral compounds
SA517381769B1 (en) Generation of peroxyformic acid through polyhydric alcohol formate
MX2017005834A (en) Aadc polynucleotides for the treatment of parkinson's disease.
PH12014502010A1 (en) Bispecific antibodies against human tweak and human il17 and uses thereof
MY176489A (en) Novel tricyclic compounds as anticancer agents
MX349004B (en) New compounds.
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
GB201118656D0 (en) New compounds
MX2013008390A (en) Preparation of metal-triazolate frameworks.
EP2938616A4 (en) The present invention relates to process for the preparation of tofacitinib and intermediates thereof.
UA111186C2 (en) Methods and compositions for preparing noribogaine from voacangine
WO2012106393A3 (en) Withanolide isolated from physalis longifolia and analogs and methods of use thereof
IN2015KN00323A (en)
MX362271B (en) A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof.
MX2014002996A (en) Bispecific anti-egfr/anti igf-1r antibodies.
MX2014005510A (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
MX2015006915A (en) Preparation of a stable beverage.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
PH12017500120A1 (en) Methods of improving myocardial performance in fontan patients using udenafil compositions
MX2013014488A (en) Methods and compositions for treating brain cancer.
IN2013CH04906A (en)
GB201107985D0 (en) Process
IN2013MU01113A (en)
IN2014CH00304A (en)